Some attempts have been made in assaying glutamic-acid decarboxylase autoantibodies (GADA) in type 1 diabetic patient (T1DM) saliva. However, these salivary assays did not show sufficient sensitivity and specificity in comparison to serum assays. In this study we evaluated the ability of a fluid-pha...
Détails bibliographiques
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 131(2009), 2 vom: 02. Mai, Seite 271-6
|
|---|
| Auteur principal: |
Tiberti, Claudio
(Auteur) |
|---|
| Autres auteurs: |
Shashaj, Blegina,
Verrienti, Antonella,
Vecci, Elio Giancarlo,
Lucantoni, Federica,
Masotti, Donata,
Morano, Susanna,
Sulli, Nicoletta,
Dotta, Francesco |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2009
|
|---|
| Accès à la collection: | Clinical immunology (Orlando, Fla.)
|
|---|
| Sujets: | Journal Article
Research Support, Non-U.S. Gov't
Autoantibodies
ICA512 autoantibody
Glutamate Decarboxylase
EC 4.1.1.15 |
|---|